Advertisement
Table 3 Study population
| Patients (n = 26) | Volunteers (n = 16) | p value | |
|---|---|---|---|
| Demographics | |||
| Age, years | 53 ± 13 | 43 ± 14 | < 0.001 |
| Male, n (%) | 17 (65) | 10 (63) | 0.91 |
| BMI, kg/m2 | 29 ± 6 | 26 ± 3 | 0.004 |
| BSA, m2 | 1.91 ± 0.27 | 1.83 ± 0.24 | 0.33 |
| HR, bpm | 68 ± 17 | 63 ± 17 | 0.73 |
| PVC, n (%) | 1 (4%) | – | – |
| Cardiovascular risk factors | |||
| Hypertension, n (%) | 17 (65) | 1 (6) | – |
| Diabetes, n (%) | 8 (31) | – | – |
| Hypercholesterolemia, n (%) | 11 (42) | – | – |
| Smoking, n (%) | 10 (39) | – | – |
| Diagnosis | |||
| HCM, n (%) | 7 (27) | – | – |
| Ischemic heart disease, n (%) | 6 (24) | – | – |
| Chagas heart disease, n (%) | 3 (11) | – | – |
| DCM, n (%) | 3 (11) | – | – |
| Other cardiomyopathies, n (%) | 7 (27) | – | – |
| CMR findingsa | |||
| LVEDVI, mL/m2 | 92 ± 50 | 66 ± 10 | 0.01 |
| LVESVI, mL/m2 | 52 ± 53 | 26 ± 10 | 0.04 |
| LVMI, g/m2 | 80 ± 28 | 54 ± 10 | < 0.001 |
| LVSV, mL | 76 ± 25 | 75 ± 15 | 0.90 |
| LVEF, % | 52 ± 21 | 62 ± 5 | 0.05 |
